Uncle Keith predicted that alirocumab would roll out in UNS syringes and AIs. Unfortunately, he got it wrong. Let's hope AMGN puts the heat on SNY/REGN to put renewed focus on the larger dose that requires WIs or else this drug will result in zero revenue for UNS holders...instead of the $1 billion projected by Uncle Keith.
Excerpt from Sanofi-Regeneron Q&A, page-41
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)